JavaScript is disabled for your browser. Some features of this site may not work without it.
Please note that UPSpace will be unavailable from Friday, 2 May at 18:00 (South African Time) until Sunday, 4 May at 20:00 due to scheduled system upgrades. We apologise for any inconvenience this may cause and appreciate your understanding.
Pregnancy-related venous thromboembolic events are important preventable causes of morbidity and mortality in South Africa. All
pregnant patients should be evaluated for thrombotic risk at different stages of their pregnancy and appropriate preventive steps taken.
Maternal and fetal wellbeing must be kept in mind, as well as physiological changes leading to altered drug pharmacokinetics. Managing
the patient with thrombotic risk in pregnancy, diagnosing venous thromboembolism (VTE) during pregnancy and treatment of venous
thromboembolic events should be managed by a team. Excellent recent reviews on this subject are available, including risk factor
stratification in anticoagulant therapy; managing the patient at time of labour; diagnosing VTE; and managing neuraxial anaesthesia in the
pregnant patient on anticoagulant therapy.